Skip to main content
. 2022 Oct 20;36(11):2586–2595. doi: 10.1038/s41375-022-01696-w

Fig. 6. METTL3 mediates AML chemoresistance by regulating ITGA4.

Fig. 6

A ITGA4 appears at a high frequency in multiple migration and adhesion pathways. B The improvement of migration and adhesion in METTL3-overexpressing AML cells can be partly reversed by an ITGA4 inhibitor (TR-14035). ***P < 0.001, ****P < 0.0001, vs. the NC group under DMSO treatment; #P < 0.05, ##P < 0.01, ###P < 0.001, vs. the NC group under TR-14035 treatment; Ω, significant TR-14035 treatment effect; &, significant interaction effect; two-way ANOVA. Bar, 200 μm. C EdU incorporation assay showing that the improvement in the percentage of METTL3-overexpressing AML cells entering the proliferation cycle with IDA pressure can be partly reversed by TR-14035. *P < 0.05, **P < 0.01; ***P < 0.001; t test. n ≥ 3, mean ± SD values are shown for (B) and (C).